Evidence map›Paper›PMID 15309347›Full record

ArticleImmunogenetics2004

Identification of HLA-Cw6.02 and HLA-Cw7.01 allele-specific binding motifs by screening synthetic peptide libraries.

Sara O Dionne, Douglas F Lake, William J Grimes, Margaret H Smith

Abstract read
PubMed Publisher
In one paragraph

Article in Immunogenetics, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Melanocyte antigen triggers autoimmunity in human psoriasis.The Journal of experimental medicine · 2015
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sara O DionneDepartment of Microbiology and Immunology, Arizona Cancer Center, University of Arizona, Tucson, AZ 85724, USA.
Douglas F Lake
William J Grimes
Margaret H Smith
University of Arizona · US

Funding

Custon Designing Peptides for Cancer ImmunotherapyR01CA094852 · NCI · UNIVERSITY OF ARIZONA · PI LAKE, DOUGLAS F · 2002 to 2005
$1.1M
HLA CLASS I PRESENTATION OF HIV PEPTIDESR29AI036712 · NIAID · UNIVERSITY OF ARIZONA · PI SMITH, MARGARET H · 1995 to 1999
–
NCI NIH HHS R01CA94852NIAID NIH HHS R29AI36712
6 · The paper itself

Abstract

Unlike HLA-A and HLA-B, few peptide epitope motifs have been reported for HLA-C molecules. However, a number of cytotoxic T-lymphocyte epitopes derived from tumor antigens that bind to HLA-C molecules have been described. Here we report peptide-binding motifs for both HLA-Cw6.02 and HLA-Cw7.01 molecules. Recombinant human HLA molecules were generated and used to screen combinatorial 9mer peptide libraries. Complexes of HLA molecules properly folded and associated with beta2-microglobulin and peptides were identified using a conformation-specific HLA class I antibody conjugated to alkaline phosphatase. In the presence of substrate, peptide beads can be readily isolated and microsequenced to determine peptide identity. Of the peptides that bound to HLA-Cw6.02 and HLA-Cw7.01, 19 and 18 peptides, respectively, were sequenced, allowing motif identification for each C allele. This is the first report of an HLA-Cw7.01 peptide motif and extends the findings of Falk et al. [(1993) Proc Natl Acad Sci USA 90:12005] for an HLA-Cw6.02 motif. Anchoring amino acids for the HLA-Cw6.02 motif were phenylalanine or tyrosine in position (P)1, arginine in P2, and an aliphatic/aromatic residue at P9. Anchoring residues for HLA-Cw7.01 were positively charged amino acids in P1 and P2. Unlike most other HLA molecules, we were unable to assign P9 an anchoring residue, and we suspect that HLA-Cw7.01 binds peptides in an unconventional manner. Additionally, preferred amino acids were identified for both molecules. Identification of HLA-Cw6.02 and HLA-Cw7.01 peptide-binding motifs makes a significant contribution to the C allele peptide-binding motifs and will allow investigators to predict, design, and test HLA-Cw6.02 and HLA-Cw7.01 engineered peptides for immunotherapy.

Indexed as

Alkaline PhosphataseAllelesbeta 2-MicroglobulinBinding SitesCells, CulturedCombinatorial Chemistry TechniquesEpitopesHLA-C AntigensHumansImmunoconjugatesLymphocytesPeptide FragmentsPeptide LibraryProtein BindingRecombinant ProteinsAlkaline Phosphatasebeta 2-MicroglobulinEpitopesHLA-C*06 antigenHLA-C*70 antigenHLA-C AntigensImmunoconjugatesPeptide FragmentsPeptide LibraryRecombinant Proteins

Identifiers

PMID15309347
OpenAlexW2084443909

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.